Research of the antimalarial drugs from the natural products
Research of the antimalarial drugs from the natural products
批准号:
11307052
负责人:
OMURA Satoshi
金额:
$25.77万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2002
中文摘要
从天然产物中寻找新型的抗疟药物。在为期4年的研究期间,12832份天然产物样品被提供给北里筛选中心进行体外抗疟筛选。因此,我们选择了18种天然产物作为候选材料,这些天然产物具有选择性和有效的抗疟活性,必须进一步从这些材料中分离和纯化活性化合物。在从微生物代谢产物的研究过程中,我们发现已知的五种抗生素由放线菌菌株K99-0413、KP-4050、K99-5147、KP-4093产生的(X-206、K-41、聚酮霉素、疏螺旋体素和leucinostatin A)OM-0060和FKI-0266分别具有较强的体外抗疟活性和选择性。此外,我们还发现本研究所抗生素库中的高卡霉素(与激素霉素鉴别)和八环霉素具有较强的体外活性。此外,X-206、K-41和疏螺旋体素的体内抗疟活性比蒿甲醚、青蒿琥酯和氯喹更强。尤其是K-41和疏螺旋体素具有作为新型抗疟药物的先导化合物的可能性,对K-41和疏螺旋体素的进一步详细研究正在进行中。在对植物资源的研究过程中,我们发现从印度王哥林根中分离得到两个已知的双黄酮类化合物sikokianins B和C,具有一定的体外抗疟疾活性。这些化合物的抗疟活性是首次报道。现在,我们正在测量其他天然化合物的抗疟疾活性,如海洋产品和来自天然产品的合成化合物,并正在从其他天然产品中分离活性物质。
英文摘要
We had researched to discover new type of the antimalarial drugs from the natural products. During the research period of 4 years, 12, 832 samples as the natural products were supplied to the Kitasato screening center for in vitro antimalarial screening. As a result, we selected the candidate materials as 18 natural products that had selective and potent antimalarial activities, which must be examined further isolation and purification of active compounds from those materials. In the course of the research from the microbial metabolites, we found that the five known antibiotics (X-206, K-41, polyketomycin, borrelidin and leucinostatin A) produced by actinomycete strains K99-0413, KP-4050, K99-5147, KP-4093 (later, OM-0060 was selected as highly productive strain) and a fungal strain FKI-0266, respectively, had potent and selective antimalarial activities in vitro. Further, we found that takaokamycin (identified with hormomycin) and octacyclomycin, own compounds in the antibiotic library of our institute, had potent activity in vitro. Furthermore, the in vivo antimalarial activities of X-206, K-41 and borrelidin exhibited more potent activities than those of the existed antimalarial drugs as artemether, artesunate and chloroquine. Especially, K-41 and borrelidin has the possibility of the lead compounds as the new type of the antimalarial drugs, further detail studies of K-41 and borrelidin are in progress. In the course of the research from the plant resources, we found that two known biflavonoids as sikokianins B and C were isolated from the root of Wikstroemia indica, had moderate antimaralial activities in vitro. There are the first reports to show antimalarial activities of the above compounds. Now, we are ongoing to measure the antimalarial activities of other natural compounds as marine products and synthetic compounds derived from the natural products, and also ongoing to isolate active substances from the other natural products.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Uchiro, H., K.Otoguro, S.Omura., et al.: "Remarkable influence of the aromatic substructure in 9-methoxystrobilurin derivatives on their antifungal activity"Bioorg. Med. Chem. Lett.. 12. 2699-2702 (2002)
Uchiro, H.、K.Otoguro、S.Omura. 等人:“9-甲氧基甲氧基丙烯酸酯衍生物中的芳香亚结构对其抗真菌活性的显着影响”Bioorg。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
乙黒 一彦: "抗マラリア剤の探索研究-JPMWプロジェクトを中心に-"動物の原虫病. 16・2. 43-53 (2001)
小黑和彦:“抗疟药的探索性研究 - 关注 JPMW 项目 -”动物原虫疾病 16・2(2001 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
杉野幸夫, 大村 智: "日本からの新規抗マラリア剤の開発をめざして"ファルマシア. 36(12). 1054-1058 (2000)
Yukio Sugino、Satoshi Omura:“旨在开发日本的新型抗疟药”Pharmacia 36(12) (2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Otoguro, K.: "Research for antimalarial drugs (Japanese)"J.Animal Protozooses. 16(2). 43-53 (2001)
Otoguro, K.:“抗疟药物的研究(日语)”J.Animal Protozooses。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 24 条
Studies on fungal pyripyropenes, potent inhibitors of cholesterol metabolism
-
批准号:07457525
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.99万
-
财政年份:1995
-
负责人:OMURA Satoshi
-
依托单位:
Inhibition of foam cell formation : Application to the discovery of novel antiatherosclerotic agents
-
批准号:02557094
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$9.54万
-
财政年份:1990
-
负责人:OMURA Satoshi
-
依托单位:
Construction of Streptomyces-Eschetichia coli bifunctional cosmid and cloning of antibiotic biosynthetic genes.
-
批准号:61571079
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1986
-
负责人:OMURA Satoshi
-
依托单位:
海外基金